Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Aphranel MagiCCrystal
- Development stage
- Unknown
- Lead developer
- Shanghai Moyom Biotechnology
- Administration
- Intradermal, Subcutaneous
01
Overview
Aphranel MagiCCrystal is a regenerative medical aesthetic injectable device developed by Shanghai Moyom Biotechnology. It is formulated as 30% calcium hydroxylapatite (CaHA) microspheres suspended in a 70% carboxymethyl cellulose (CMC) gel carrier. The product utilizes proprietary ACD-MT® 'raspberry-like' through-hole porous microsphere technology and PCD-ETT® physically crosslinked CMC gel technology. Its primary mechanism involves the biostimulation of fibroblasts to promote collagen regeneration and tissue integration, providing both immediate structural support and long-term skin quality improvement. It is indicated for facial aesthetic applications, including structural contouring and volume restoration in areas such as the forehead, midface, and jawline. Aphranel MagiCCrystal is the first CaHA filler to receive NMPA Class III medical device certification in China and has also achieved EU MDR certification.
- Brand names
- Aphranel MagiCCrystalAphranel
- Other names
- Calcium Hydroxylapatite (CaHA) Microsphere Injectable Facial FillerAphranel MagiCCrystal CaHA Filler
Beyond the preview
Go deeper on Aphranel MagiCCrystal.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Aphranel MagiCCrystal.